8-K ·Filed Mar 11, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
Monitor for supplemental disclosures or press releases from Biogen regarding leadership changes. Absent details, this event should not drive trading decisions.
Final — all horizons settled through T+60d
BIIB ▲ +6.11% at T+60d
NEUTRAL call ✓ call won +6.11% · α vs SPY -4.59% · entry $184.10 → $195.34
T+1d
-1.69%
call -1.69% · α -1.10%
$180.98
settled 7mo ago
T+5d
-0.66%
call -0.66% · α +0.32%
$182.88
settled 7mo ago
T+20d
-6.11%
call -6.11% · α -8.08%
$172.86
settled 6mo ago
T+60d
+6.11%
call +6.11% · α -4.59%
$195.34
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Analysis based on filing metadata only — document content was unavailable. The filing is an 8-K with Item 5.02 disclosed, indicating a departure or appointment of directors or officers at Biogen Inc. (BIIB), but no details are available to assess the nature, participants, or implications of the change.
Key Facts
- Filing type is 8-K, indicating a material event.
- Item 5.02 reported: Departure or appointment of directors or officers.
- No document content available to determine who was involved, whether it was a resignation, retirement, or termination, or if a replacement was named.
Financial Impact
Not specified
Risk Factors
- Potential for unexpected executive turnover if the departure was involuntary or involved C-suite executives.
- Lack of transparency due to unavailable filing content limits ability to assess governance stability.
Market Snapshot
Exchange
Nasdaq
Analyst Consensus
47% bullish (43 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
Report based on filing metadata.
25 reports for BIIB
92% Hit rate best @ T+60▲ +11.76%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 3, 2026 28d ago | Press Release | $220.83 $217.36 | ▼ −1.57% | ▼ −0.36% | $219.88 (−0.43%) |
Sep 3, 2026 29d ago | Press Release | $224.51 $217.15 | ▼ −3.28% | ▼ −2.13% | $219.88 (−2.06%) |
Aug 6, 2026 8w ago | Press Release | $207.94 $209.83 | ▲ +0.91% | ▲ +0.51% | $219.88 (+5.74%) |
Jul 14, 2026 11w ago | Press Release | $191.95 $199.95 | ▲ +4.17% | ▲ +5.46% | $219.88 (+14.55%) |
Jul 13, 2026 11w ago | Press Release | $191.95 $199.95 | ▲ +4.17% | ▲ +5.46% | $219.88 (+14.55%) |
Jul 13, 2026 11w ago | ANALYST-UPGRADE | — | awaiting T+5 | — | — |
Jun 17, 2026 15w ago | Press Release | $196.58 $201.96 | ▲ +2.74% | ▲ +4.40% | $219.88 (+11.85%) |
Jun 8, 2026 16w ago | ANALYST-UPGRADE | $192.62 $198.64 | ▲ +3.13% | ▲ +1.01% | $219.88 (+14.15%) |
Jun 4, 2026 17w ago | Press Release | $195.82 $199.96 | ▲ +2.12% | ▲ +4.67% | $219.88 (+12.29%) |
Jun 1, 2026 17w ago | Press Release | $192.22 $195.34 | ▲ +1.63% | ▲ +4.38% | $219.88 (+14.39%) |
Showing 10 of 25
US Market Status
Market Closed — Opens Mon (65h 6m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access